Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration

Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.
Latest website image capture
Clouds background image

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:42:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous revision. The government funding status notice and the Revision: v3.4.1 notice were removed.
    Difference
    0.2%
    Check dated 2026-02-11T12:16:11.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a system-wide notice about a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T06:40:21.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a glossary toggle, updated the label to 'Last Update Submitted that Met QC Criteria', corrected capitalization to 'No FEAR Act Data', and introduced 'Revision: v3.4.0'.
    Difference
    0.1%
    Check dated 2026-01-28T06:25:28.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No visible changes to study details or navigation.
    Difference
    0.0%
    Check dated 2026-01-21T04:06:09.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now includes a consolidated Locations section listing participating states (Alabama through Wisconsin). The HHS Vulnerability Disclosure section was removed.
    Difference
    2%
    Check dated 2025-12-23T21:09:25.000Z thumbnail image

Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration

Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.